Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if MLTX is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
39 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 77 days ago
Red flags: 2
173 filers reported a long position in MLTX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BVF INC/IL | $311.5M | 16M | Unchanged |
| Deep Track Capital, LP | $136.3M | 7M | +9.2% |
| T. Rowe Price Investment Management, Inc. | $83.3M | 4.3M | New |
| D. E. Shaw & Co., Inc. | $65.5M | 3.4M | +40.8% |
| Cormorant Asset Management, LP | $62.4M | 3.2M | -28.5% |
| Jupiter Topco LLC | $60.1M | 3.1M | — |
| Logos Global Management LP | $52.1M | 2.7M | +78.3% |
| Weiss Asset Management LP | $50.3M | 2.6M | +51.1% |
| CITADEL ADVISORS LLC | $38.4M | 2M | +49% |
| TWO SIGMA INVESTMENTS, LP | $33.4M | 1.7M | +52.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.